Updated Seroprevalence of Hepatitis B Surface Antigen and Anti-Hepatitis Core Antibody Among Blood Donors in Yemen

References

• World Health Organization. Blood safety and availability, WHO fact sheet. No. 279; 2017. Available from: http://www.who.int/mediacentre/factsheets/fs279/en/. Accessed March 20, 2021.
   Google Scholar
• World Health Organization. Blood donor selection: guidelines on assessing donor suitability for blood donation. World Health Organization; 2012 Available from: https://apps.who.int/iris/handle/10665/76724. Accessed March 20, 2021.
   Google Scholar
• World Health Organization. Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021. Accountability for the global health sector strategies 2016–2021: actions for impact. Available from: https://www.who.int/publications/i/item/9789240027077. Accessed March 20, 2021.
   Google Scholar
• United Nations Office on Drugs and Crime. HIV prevention, treatment, care and support for people who use stimulant drugs. technical guide; UNODC; Vienna; 2019. Available from: https://www.unodc.org/documents/hiv-aids/publications/People_who_use_drugs/19-04568_HIV_Prevention_Guide_ebook.pdf. Accessed March 24, 2021.
   Google Scholar
• Quadri SA, Dadapeer HJ, Arifulla M, Khan N. Prevalence of Hepatitis B surface antigen in hospital based population in Bijapur, Karnataka. Al Ameen J Med Sci. 2013;6(2):180–182.
   Google Scholar
• Sood S. Serological evaluation of Hepatitis B virus in outpatient department patients of a private hospital in North – west India. National J of Community Medicine. 2013;4:485–488.
   Google Scholar
• Alcantara JC, Alenezi FK, Haj Ali OH. Seroprevalence and trends of markers of transfusion transmissible infections among blood donors: a 3-year hospital based-study. Int J Community Med Public Health. 2018;5(12):5031–5035. doi:10.18203/2394-6040.ijcmph20184773
   Google Scholar
• Al-Gani FA. Prevalence of HBV, HCV and HIV-1, 2 infections among blood donors in Prince Rashed Ben Al-Hassan hospital in North region of Jordan. Int J Biol Med Res. 2011;2(4):912–916.
   Google Scholar
• Al-Rubaye A, Tariq Z, Alrubaiy L. Prevalence of hepatitis B seromarkers and hepatitis C antibodies in blood donors in Basra, Iraq. BMJ Open Gastroenterol. 2016;3(1):e000067. doi:10.1136/bmjgast-2015-000067
   Google Scholar
• Karim M, Lahham H. Prevalence of viral hepatitis B and C in Syria. Syr Epidemiol Bull. 2008;2(3):10–11.
   Google Scholar
• Nagi AM, Altyeb HA, Ahmed AM. Seroprevalence of Hepatitis B and C viral infections among blood donors in Shendi, River Nile State, Sudan. Res J Med Sci. 2007;2(2):122–126.
   Google Scholar
• El-Gilany AH, El-Fedawy S. Bloodborne infections among student voluntary blood donors in Mansoura University, Egypt. East Mediterr Health J. 2006;12(6):742–748.
   Google Scholar
• Alodini AQ. Prevalence of Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) infections among blood donors at Al-Thawra Hospital Sana’a City Yemen. Yemeni J Med Sci. 2014;6:54–63.
   Google Scholar
• Alzubiery T, Alharazi T, Alsumairy H, Amar J, Manal M, Majedi S. Prevalence of HBS Ag and anti-HBc among blood donors at the National Blood Transfusion and Research Center, Sana’a, Yemen. World J of Pharmaceutical Med Res. 2017;3(5):69–74.
   Google Scholar
• Al-Shamahy H. Prevalence of hepatitis B surface antigen and risk factors of HBV infection in a sample of healthy mothers and their infants in Sana’a Yemen. Ann Saudi Med. 2016;20(5–6):464–467. doi:10.5144/0256-4947.2000.464
   Web of Science ®Google Scholar
• Al-Zubiery T, Alharazi T, Alsumairy H, Al-Zubiery A. Seroprevalence of HBs Ag, HCV and HIV among blood donors in three blood bank centers in Sana’a city: Yemen. J Biotechnol Biomed. 2017;1(1):1–26. doi:10.14302/issn.2576-6694.jbbs-17-1853
   Google Scholar
• Alnwany NT. Prevalence of Hepatitis B virus infection and associated factors among blood donors in 48 Hospital Sana’a City- Yemen during 2016. J Med Pharm Allied Sci. 2020;4(1):111–126.
   Google Scholar
• Mekuria SA, Legesse TG, Yalew AW. Prevalence of Hepatitis B and C viruses among blood donors at national blood bank Addis Ababa, Ethiopia. Int j Collab Res Intern Med Public Health. 2020;12(5):1037–1042.
   Google Scholar
• Bommanahalli B, Javali R, Swamy CM, Gouda K, Siddartha K, Shashikala KP. Seroprevalence of Hepatitis B and Hepatitis C Viral infections among blood donors of central Karnataka, India. Int J Med Sci Public Health. 2014;3:1. doi:10.5455/ijmsph.2013.151220131
   Google Scholar
• Al-Dafaee ME, Jasim AZ, Mohammed TK, Mohammed RQ, Abdullah HN, Harhoosh MA. Serological detection of viral Hepatitis B and C among the blood donors in Baghdad City. J Res Lepid. 2020;51(3):220–225. doi:10.36872/LEPI/V51I3/301181
   Google Scholar
• Souan L, Siag M, Al-Salahat H, Al-Atrash T, Sughayer MA. Changing trends in seroprevalence rates of transfusion-transmitted diseases among blood donors in Jordan. BMC Infect Dis. 2021;21:508. doi:10.1186/s12879-021-06196-3
   Web of Science ®Google Scholar
• Ramli M, Zulkafli Z, Chambers GK, Amani RS, Zilan R, Edinur HA. The prevalence of transfusion-transmitted infections among blood donors in hospital universiti Sains Malaysia. Oman Med J. 2020;35(6):e189. doi:10.5001/omj.2020.86
   Google Scholar
• Alzahrani FM, Muzaheed SSS, Alomar AI, Acharya S, Elhadi N, Elhadi N. Prevalence of Hepatitis B Virus (HBV) among blood donors in Eastern Saudi Arabia: results from a five-year retrospective study of HBV seromarkers. Ann Lab Med. 2019;39:81–85. doi:10.3343/alm.2019.39.1.81
   Web of Science ®Google Scholar
• Bazie EA, Alhasan Ali MM, Hamza HB, Magzoub OS, Salih MSM, Haroun BE. Sero-prevalence of viral transfusion-transmissible infections among blood donors at Kosti Teaching Hospital, White Nile State/Sudan. Int J Curr Microbiol App Sci. 2015;4(5):1132–1138.
   Google Scholar
• Umolu PI, Okoror LE, Orhue P. Human immunodeficiency virus (HIV) seropositivity and hepatitis B surface antigenemia (HBSAG) among blood donors in Benin City, Edo state, Nigeria. Afr Health Sci. 2005;5:1.
   Google Scholar
• Abebe M, Alemnew B, Biset S. Prevalence of Hepatitis B virus and HepatitisC virus among blood donors in nekemte blood bank, Western Oromia, Ethiopia: retrospective 5Years Study. J Blood Med. 2020;11:543–550. doi:10.2147/JBM.S282099
   Web of Science ®Google Scholar
• Nwobegahay JM, Njukeng PA, Kengne M, et al. Prevalence of Hepatitis B virus infection among blood donors at the Yaounde Military Hospital. Microbiol Res Int. 2016;4:6–10.
   Google Scholar
• Police SMC, Bessanguem B, Mofini E, et al. High prevalence of Hepatitis B virus infection compared to human immunodeficiency virus among blood donors in Bangui. Open J Gastroenterol. 2020;10:137–143. doi:10.4236/ojgas.2020.106014
   Google Scholar
• Boushab BM, Limame OCMM, Zahra FMF, Mamoudou S. Estimation of seroprevalence of HIV, hepatitis B and C virus and syphilis among blood donors in the hospital of Aïoun, Mauritania. Pan African Medl J. 2017;8:118.
   Google Scholar
• Muselmani W, Habbal W, Monem F. Prevalence of “anti-HBc alone” among Syrian blood donors. J Infect Dev Ctries. 2014;8(8):1013–1015. doi:10.3855/jidc.3827
   Web of Science ®Google Scholar
• Lavanya V, Viswanathan T, Malar SAS, Malarvizhi A, Moorthy K. Prevalence of hepatitis B virus infection among blood donors with antibodies to hepatitis B core antigen. Int J Med Medical Sci. 2012;4(6):128–137.
   Google Scholar
• Ebenezer BO, Toyin OO, Adebisi AY. Serological markers of Hepatitis B virus infectivity among Hepatitis B surface antigen negative blood donors at the University College Hospital, Ibadan. Niger Postgrad Med J. 2017;7(4):1–7.
   Google Scholar
• Ikerionwu B. Prevalence of Hepatitis B surface antigen and Hepatitis B core antibody among prospective blood donors in Abuja, Nigeria. Arch Blood Transfus Disord. 2017;1(5):1–5.
   Google Scholar
• Karimi G, Zadsar M, Vafaei N, Sharifi Z, Tafti MF. Prevalence of antibody to Hepatitis B core antigen and Hepatitis B virus DNA in HBsAg negative healthy blood donors. Virol J. 2016;13(36):1–6. doi:10.1186/s12985-016-0492-8
   Web of Science ®Google Scholar
• Abdullah SM. Prevalence of Hepatitis B and C in donated blood from the Jazan Region of Saudi Arabia. Malays J Med Sci. 2013;20(2):41–46.
   Google Scholar
• Chen YT, Jiang JJ. Epidemic situation of hepatitis C virus. Strait J Prev Med. 2009;15:19–21. Chinese.
   Google Scholar
• Shan H, Wang JX, Ren FR, et al. Blood banking in China. Lancet. 2002;360:1770–1775. doi:10.1016/S0140-6736(02)11669-2
   Web of Science ®Google Scholar
• Zhao SM, Jiang TL, Gao FX, et al. Analysis of true voluntary blood donors with anti-HCV prevalence and implications for donor management in Chongqing, China. Transfus Med. 2007;17:210–211. doi:10.1111/j.1365-3148.2007.00752.x
   Web of Science ®Google Scholar
• Guglielmo-Viret V, Attrée O, Blanco-Gros V, Thullier P. Comparison of electrochemiluminescence assay and ELISA for the detection of Clostridium botulinum type B neurotoxin. J Immunol Methods. 2005;301(1–2):164–172. doi:10.1016/j.jim.2005.04.003
   Web of Science ®Google Scholar
• Tognona F, Sevalie S, Gassimu J, et al. Seroprevalence of hepatitis B and hepatitis C among blood donors in Sierra Leone: a multi-year retrospective study. Int J Infect Dis. 2020;99:102–107. doi:10.1016/j.ijid.2020.07.030
   Web of Science ®Google Scholar
• Kabato AA, Weldearegay GM. Prevalence and associated risk factors of Hepatitis B and Hepatitis C virus among volunteer blood donors in Arba Minch blood bank SNNPR, Ethiopia. J Med Lab Diagn. 2016;7(4):20–27. doi:10.5897/JMLD2016.0122
   Google Scholar
• Habte Y, Seyoum B, Alemayehu T. Hepatitis B virus infection and associated factors among blood donors at Dire Dawa, Eastern Ethiopia. J Antivir Antiretrovir. 2016;8(4):103–106. doi:10.4172/jaa.1000144
   Google Scholar
• El Beltagy KE, Al Balawi IA, Almuneef M, Memish ZA. Prevalence of hepatitis B virus markers among blood donors in a tertiary hospital in Tabuk, Northwestern Saudi Arabia. Int J Infect Dis. 2008;12:495–499. doi:10.1016/j.ijid.2008.01.010
   Web of Science ®Google Scholar
• Eko Mba JM, Bisseye C, Ntsame Ndong JM, et al. Prevalent hepatitis B surface antigen among first-time blood donors in Gabon. PLoS One. 2003;13(4):e0194285. doi:10.1371/journal.pone.0194285
   Web of Science ®Google Scholar
• Paul CM, Moise KK, Blood BND, et al. Seroprevalence of Hepatitis B among blood donors in Mbuji-Mayi, “Case of Dipumba General Hospital” (DRC). Open Access Libr J. 2017;4:e3503. doi:10.4236/oalib.1103503
   Google Scholar
• Al Hroob AM, Saghir SAM, Almaiman AA, et al. Prevalence and association of transfusion transmitted infections with ABO and Rh blood groups among blood donors at the national blood bank, Amman, Jordan. Medicina. 2020;56(701):1–11. doi:10.3390/medicina56120701
   Web of Science ®Google Scholar
• Mulakoli F, Gichure M. The prevalence of antibodies to Hepatitis B core antigen among blood donors in a tertiary institution in Nairobi County, Kenya. East Africa Science. 2020;2(1):36–44. doi:10.24248/EASci-D-19-00012
   Google Scholar
• Keklik Z, Koruk I, Allahverdi S. Syrian Refugees at risk of Hepatitis diseases in Turkey. Saudi J Med. 2019;4(12):749–758. doi:10.36348/sjm.2019.v04i12.002
   Google Scholar
• Ikerionwu B. Prevalence of Hepatitis B surface antigen and Hepatitis B core antibody among prospective blood donors in Abuja, Nigeria. Arch Blood Transfus Disord. 2017;1(5):1–5.
   Google Scholar
• Al-Shamahy HA, Hanash SH, Rabbad IA, et al. Hepatitis B Vaccine coverage and the immune response in children under ten years old in Sana’a, Yemen. Sultan Qaboos Univ Med J. 2011;11(1):77–82.
   Google Scholar
• World Health Organization, UNICEF 2020. Immunization regional snapshot 2020 Middle East and North Africa. WHO-UNICEF Estimates of National Immunization Coverage (WUENIC), revision 2020/the world population prospects – 2019 revision, UN population division, New York, USA. Available from: https://data.unicef.org/resources/regional-immunization-snapshots/. Accessed April 11, 2022.
   Google Scholar